Literature DB >> 1437920

Diagnosis and management of ventricular tachycardia.

M Dancy1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1437920      PMCID： PMC2399344          DOI： 10.1136/pgmj.68.800.406

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  58 in total

1.  Nonischemic ventricular tachycardia. Clinical course and long-term follow-up in patients without clinically overt heart disease.

Authors:  R Lemery; P Brugada; P D Bella; T Dugernier; A van den Dool; H J Wellens
Journal:  Circulation       Date:  1989-05       Impact factor: 29.690

2.  Arrhythmogenic effects of antiarrhythmic drugs: a study of 506 patients treated for ventricular tachycardia or fibrillation.

Authors:  M S Stanton; E N Prystowsky; N S Fineberg; W M Miles; D P Zipes; J J Heger
Journal:  J Am Coll Cardiol       Date:  1989-07       Impact factor: 24.094

3.  Significance of the clinical presentation in ventricular tachycardia/fibrillation.

Authors:  L A Saxon; E F Uretz; P Denes
Journal:  Am Heart J       Date:  1989-10       Impact factor: 4.749

4.  Misdiagnosis of chronic recurrent ventricular tachycardia.

Authors:  M Dancy; A J Camm; D Ward
Journal:  Lancet       Date:  1985-08-10       Impact factor: 79.321

5.  Misuse of intravenous verapamil in patients with ventricular tachycardia.

Authors:  A C Rankin; A P Rae; S M Cobbe
Journal:  Lancet       Date:  1987-08-29       Impact factor: 79.321

6.  Comparison of the efficacy of propranolol and amiodarone in suppressing ventricular arrhythmias following myocardial infarction.

Authors:  C Fournier; M Brunet; M Bah; M Kindermans; B Boujon; P Tournadre; J F Giudicelli; M Blondeau
Journal:  Eur Heart J       Date:  1989-12       Impact factor: 29.983

7.  Electrophysiologic effects of epinephrine in humans.

Authors:  F Morady; S D Nelson; W H Kou; R Pratley; S Schmaltz; M De Buitleir; J B Halter
Journal:  J Am Coll Cardiol       Date:  1988-06       Impact factor: 24.094

8.  Usefulness of sotalol in suppressing ventricular tachycardia or ventricular fibrillation in patients with healed myocardial infarcts.

Authors:  D L Kuchar; H Garan; F J Venditti; D Finkelstein; J N Rottman; J McComb; B A McGovern; J N Ruskin
Journal:  Am J Cardiol       Date:  1989-07-01       Impact factor: 2.778

9.  The role of beta blocking agents as adjunct therapy to membrane stabilizing drugs in malignant ventricular arrhythmia.

Authors:  G Hirsowitz; P J Podrid; S Lampert; J Stein; B Lown
Journal:  Am Heart J       Date:  1986-05       Impact factor: 4.749

10.  The value of the clinical history to assess prognosis of patients with ventricular tachycardia or ventricular fibrillation after myocardial infarction.

Authors:  P Brugada; M Talajic; J Smeets; R Mulleneers; H J Wellens
Journal:  Eur Heart J       Date:  1989-08       Impact factor: 29.983
View more
  1 in total

1.  Diagnosis and management of ventricular tachycardia.

Authors:  O M Jolobe
Journal:  Postgrad Med J       Date:  1993-02       Impact factor: 2.401
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.